BACK of the BOOK
Heard in the Blogosphere
March is DVT Awareness Month
Throughout the month, ASH will be sharing myths
about this serious and underdiagnosed medical
condition.
Share this information with your patients
to help spread the word about blood clots!
ASH
@ASH_Hematology
Greg Vercellotti, MD,
an ASH advocate from
#Minnesota, met with
@alfranken last week to
discuss #NIH funding.
Naveen Pemmaraju, MD
@doctorpemm
Wow. It has been almost 10 years to the date that #JAK2V617F
mutation was first described. What a journey for patients &
providers.
Sh** Academics Say
@AcademicsSay ()
Yes, I’ve heard of work-life balance. I gave a workshop on it
last week and am co-editing a related special issue to which
I’m contributing.
Amber Yates
High-Cost and High-Value: Are Expensive Cancer Drugs Worth it? ... p. 18
@sicklecelldoc
Just finished reading
my March issue of
@ASHClinicalNews
One of the few things
I read cover to cover.
Keep it coming!
Your source for worldwide news and
perspectives on hematology/oncology
march 2015
volume 01 | number 03
CONTENTS
5… Editor's Corner
A Few of My Least
Favorite Things
Defending
9… Pulling Back the Curtain
Beverly Mitchell on
Knowing Your Passion
Your
Spleen
11… Hematology Link
Managing High Blood
Pressure
14… Advanced Practice
Perspectives
Caregivers and
Chronic Disease
Can Rituximab
Replace Splenectomy
for ITP Patients?
39… How I Teach
Alison Loren
on Mentoring
50… PASHions
Guy Young:
Hematologist, Novelist
DEPARTMENTS
5 UP FRONT
15 CLINICAL NEWS
38 TRAINING AND EDUCATION
43 FEATURES
50 BACK OF THE BOOK
www.ASHClinicalNews.org
Latest & Greatest:
Drug and Device
News ... 15
The Road to Cancer Treatment Through
Clinical Trials
“No matter what you do in the lab or in basic science, the ultimate
proof of which cancer medicines work comes from clinical trials.
[Only 5 percent of adults with cancer enter a clinical trial.] That’s not
nearly enough to move cancer medicine forward.”
Literature Scan:
New & Noteworthy
Research ... 24
Patient Education:
What is Multiple
Myeloma?... 41
Why the War on Cancer Hasn’t Been Won
The Ugly Civil War in American Medicine
“Over the last 10 to 15 years we began to accumulate once again an
overwhelming mass of information that cancer is indeed a highly
complex process, and that attempts at distilling it down to a small
number of simple processes may not really work that easily. Once
again, we’re caught in this quandary: How can we understand this
complexity in terms of a small number of underlying basic principles?”
“We don’t want to do meaningless work and we don’t want to pay
fees that are unreasonable and we don’t want to line the pockets of
administrators. [Medicine has been] controlled by individuals who
are not involved with the day-to-day care of patients. It is time for
practicing physicians to take back the leadership.”
—Paul Teirstein, MD, in Newsweek, speaking about ABIM certification
—Siddhartha Mukherjee, MD, PhD, in The New York Times
—Robert Weinberg, PhD, on NPR’s All Things Considered
52
ASH Clinical News
April 2015